Related Experiment Video

Updated: Aug 17, 2026

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction
14:19

Fetal Echocardiography and Pulsed-wave Doppler Ultrasound in a Rabbit Model of Intrauterine Growth Restriction

Published on: June 29, 2013

Impaired fetal growth: definition and clinical diagnosis

J W Seeds

    Obstetrics and Gynecology
    |September 1, 1984
    PubMed

    Insights

    Intrauterine growth retardation (IUGR) affects up to 10% of pregnancies, increasing risks for newborns. This review clarifies IUGR definitions and diagnostic methods for impaired fetal growth.

    Area of Science:

    • Obstetrics and Gynecology
    • Fetal Medicine
    • Neonatal Perinatal Medicine

    Background:

    • Intrauterine growth retardation (IUGR) affects up to 10% of pregnancies, leading to increased perinatal morbidity and mortality.
    • Causes of IUGR include uteroplacental insufficiency, genetic factors, infections, and drug exposure.
    • Inconsistent diagnostic criteria hinder research on IUGR's short- and long-term implications.

    Purpose of the Study:

    • To examine the significance and clinical definition of Intrauterine growth retardation (IUGR).
    • To review diagnostic tests for detecting impaired fetal growth.
    • To outline the clinical approach to managing IUGR, including ultrasonic evaluation.

    Main Methods:

    • Literature review of existing studies on Intrauterine growth retardation (IUGR).
    • Analysis of diagnostic criteria and tests for impaired fetal growth.
    • Examination of clinical management strategies for IUGR.

    Main Results:

    • IUGR definition inconsistencies have impeded clinical research.
    • Various diagnostic tests are available for detecting impaired fetal growth.
    • Management strategies involve ultrasonic evaluation and specific interventions.

    Conclusions:

    • Standardized diagnostic criteria are crucial for advancing IUGR research.
    • Accurate detection and timely management of IUGR are essential for improving perinatal outcomes.
    • Further research is needed to fully understand and address the implications of IUGR.

    More Related Videos

    A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis06:19

    A Rat Model of Mild Intrauterine Hypoperfusion with Microcoil Stenosis

    Published on: January 7, 2018

    High Frequency Ultrasound for the Analysis of Fetal and Placental Development In Vivo06:43

    High Frequency Ultrasound for the Analysis of Fetal and Placental Development In Vivo

    Published on: November 8, 2018

    Related Concept Videos

    Abnormal Proliferation02:23

    Abnormal Proliferation

    Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
    Teratogenicity01:07

    Teratogenicity

    The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
    Inborn Errors of Metabolism01:20

    Inborn Errors of Metabolism

    Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
    Diabetes Mellitus: Type 2 and Gestational01:22

    Diabetes Mellitus: Type 2 and Gestational

    Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
    Pathophysiology of Diabetes01:20

    Pathophysiology of Diabetes

    Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
    Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
    Intellectual Disability01:29

    Intellectual Disability

    Intellectual disability (ID) is a neurodevelopmental condition characterized by deficits in intellectual and adaptive functioning that manifest during the developmental period. This condition encompasses challenges in reasoning, memory, problem-solving, and learning, accompanied by impairments in everyday life skills, such as communication, self-care, and social interactions. Intellectual disability affects approximately 1% of the population in the United States, impacting an estimated 5...